Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors

Immunity

Volumn 1, Issue 9, 1994, Pages 793-801

  Linsley, Peter S ^a   Greene, JoAnne L ^a   Brady, William ^a   Bajorath, Jürgen ^a   Ledbetter, Jeffrey A ^a   Peach, Robert ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 2 PROTEIN; B7 ANTIGEN; B7-2 PROTEIN; CD28 ANTIGEN; COMPLEMENTARY DNA; CTLA-4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; HYBRID PROTEIN; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; BINDING SITE; CHEMISTRY; CHO CELL; COMPARATIVE STUDY; GENETICS; HAMSTER; HUMAN; IMMUNOLOGY; KINETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE;

ANIMAL; ANTIGENS, CD28; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; BINDING SITES; CHO CELLS; COMPARATIVE STUDY; DNA, COMPLEMENTARY; HAMSTERS; HUMAN; KINETICS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

EID: 0028675006     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(94)80021-9     Document Type: Article

References (37)

1. A fluorometric assay for the quantitation of cell adherence to endothelial cells
2. B70 antigen is a second ligand for CTLA-4 and CD28
3. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells
4. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4
5. T cell receptor—MHC class I peptide interactions: affinity, kinetics, and specificity
6. B7, a new member of the immunoglobulin superfamily with unique expression on activated and neoplastic B cells
7. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
8. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation
9. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production
10. Identification of a CTLA-4 ligand costimulatory for T cell activation
11. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function
12. Adhesive receptors on hematopoietic cells
13. Molecules involved in T-cell costimulation
14. Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors
15. The B7 and CD28 receptor families
16. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells
17. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
18. Expression and functional significance of an additional ligand for CTLA-4
19. Role of the CD28 receptor during T cell responses to antigen
20. The T cell antigen, CD28, mediates adhesion with B cells by interacting with the activation antigen, B7/BB-1
21. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation
22. CTLA-4 is a second receptor for the B cell activation antigen B7
23. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
24. Coexpression and functional cooperativity of CTLA-4 and CD28 on activated T lymphocytes
25. Extending the B7 (CD80) gene family
26. Clonal expansion vs. functional clonal inactivation: a costimulatory pathway determines the outcome of T cell receptor occupancy
27. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1
28. Evidence for an additional ligand distinct from B7, for the CTLA-4 receptor
29. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
30. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm
31. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2
32. Expression and function of B7 on human epidermal Langerhans cells
33. Induction of alloantigen specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB-1
34. T cell activation by the CD28-ligand B7 is required for cardiac allograft rejection in vivo
35. CTLA4Ig treatment ameliorates the lethality of murine graft-versus-host disease across major histocompatibility barriers
36. A major costimulatory molecule on antigen-presenting cells, CTLA4 ligand A, is distinct from B7
37. B lymphoblast antigen (BB-1) expressed on Epstein—Barr virus activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas